Chris currently manages HGF Oppositions and Appeals Team and is the Office Head of our Birmingham Office.
Chris' practice spans the chemical and engineering fields with particular interest in electrochemistry, fuel cells, polymers, ceramics and materials on the chemistry side as well as the health care, FMCG (e-cigarettes) automotive and construction industries.
Oppositions at the European Patent Office (EPO) provides a majority of Chris' practice where he works on high-value, business-critical patents (defensively and offensively) for a number of large clients.
Chris also has an active due diligence practice, providing advice on IP aspects of commercial M & A deals and has acted as a UK patent expert in foreign litigation.
Chris works with his clients (whether they be multinationals, SMEs or universities) to provide high-quality, focused advice to ensure that maximum returns can be achieved.
"Chris Moore [is a] patent practice leader"
"Chris Moore has his fingers in many technical pies. From chemistry to plastic electronics and fuel cells, his is the number to call for impeccable oppositions and appeals representation."
"Head of oppositions and appeals Chris Moore in Birmingham is a key patent attorney practitioner"
October 7th 2021
November 20th 2020
Chris provides pro bono IP support to a number of business incubators in the West Midlands area, including the Bizz Inn in Birmingham.
Chris regularly talks at various events to provide IP training.
Chris was, until recently, the principal examiner for the UK patent attorney professional examinations (FD4 Infringement and Validity) and is now becoming a mentor for trainees.
Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …Event details
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.